Delve Health combines eCOA/ePRO, wearable device integration, real-time analytics, and Concierge-as-a-Service™ into one clinical trial execution platform. Designed for sponsors, CROs, and research sites running hybrid and decentralized studies, Delve achieves 92–98% ePRO completion rates through proactive patient outreach in 120+ languages, device compliance monitoring, signal quality control, and site burden reduction. Used across oncology, CNS, cardiovascular, rare disease, respiratory, and post-market programs globally.